US › Healthcare

Perspective Therapeutics Inc. (CATX)

US · Healthcare · Medical Devices

$3.00-0.33%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$76,000

Revenue YoY

-77.8%

Net profit

$-26.2M

Profit YoY

-44.1%

EPS

$-0.25

EPS estimate

$-0.32

Net margin

-34,459.2%

EPS came in at -0.25 against a street estimate of -0.32 — a beat of 21.9%.

Key statistics

Market cap

$327.3M

Forward P/E

25.7

P/B

0.94

Book value

$3.05

EPS (TTM)

$-1.41

52-week high

$6.16

52-week low

$1.96

50-day MA

$3.27

200-day MA

$3.56

Beta

1.75

Analyst view

Analysts rate Perspective Therapeutics Inc. a strong buy (13 buy, 1 hold, 0 sell out of 14) with an average price target of $12.93.

Shareholding

Insiders

10.81%

Institutions

78.56%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Perspective Therapeutics Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.